tiprankstipranks
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market

Tango Therapeutics (TNGX) Income Statement

Compare
310 Followers

Tango Therapeutics Income Statement

Last quarter (Q4 2024), Tango Therapeutics's total revenue was $4.12M, a decrease of -24.19% from the same quarter last year. In Q4, Tango Therapeutics's net income was $-37.67M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 42.07M$ 36.53M$ 24.86M$ 37.04M$ 7.66M
Gross Profit
$ 42.07M$ -78.67M$ 20.83M$ 35.08M$ 6.03M
Operating Expenses
$ 187.66M$ 150.70M$ 135.93M$ 95.23M$ 59.86M
Depreciation and Amortization
$ 0.00$ 2.42M$ 4.03M$ 1.97M$ 1.63M
EBITDA
$ -145.59M$ -111.76M$ -109.46M$ -57.29M$ -51.48M
Operating Income
$ -145.59M$ -114.17M$ -111.07M$ -58.19M$ -52.20M
Other Income/Expenses
$ 15.50M$ 12.56M$ 2.95M$ 247.00K$ 228.00K
Pretax Income
$ -130.09M$ -101.61M$ -108.12M$ -57.94M$ -51.97M
Net Income
$ -130.30M$ -101.74M$ -108.18M$ -58.23M$ -51.86M
Per Share Metrics
Basic EPS
$ -1.19$ -1.08$ -1.23$ -0.94$ -1.62
Diluted EPS
$ -1.19$ -1.08$ -1.23$ -0.94$ -1.62
Weighted Average Shares Outstanding
109.23M 94.57M 87.82M 62.11M 31.93M
Weighted Average Shares Outstanding (Diluted)
109.23M 94.57M 87.82M 62.11M 31.93M
Currency in USD

Tango Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis